Literature DB >> 11431100

Effect of bile acids on formation of azoxymethane-induced aberrant crypt foci in colostomized F344 rat colon.

C X Lin1, A Umemoto, M J Seraj, S Mimura, Y Monden.   

Abstract

The effect of bile acids on the formation of azoxymethane induced aberrant crypt foci (ACF) was investigated using the fecal stream-excluded colons of colostomized F344 rats. The excluded colon was irrigated with saline or bile acids (1 mg/0.5 ml per day, 5 days/week) for 4 weeks. The mean numbers of ACF per colon in rats given cholic acid, deoxycholic acid (DCA), chenodeoxycholic acid (CDCA), lithocholic acid, and ursodeoxycholic acid (UDCA) were 160.8, 118.2, 227.8, 150.7 and 87.3, respectively, while that of the control was 174.0. The number of ACF was significantly larger in CDCA, but smaller in UDCA and DCA-treated rats than the control (P<0.01). DCA did not induce apoptosis in the colon under the present conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431100     DOI: 10.1016/s0304-3835(01)00525-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells.

Authors:  Hua Wu; Yayu Lin; Wengang Li; Zhe Sun; Weiwei Gao; Haiping Zhang; Lei Xie; Fuquan Jiang; Bin Qin; Tingdong Yan; Liqun Chen; Yi Zhao; Xihua Cao; Yin Wu; Bingzhen Lin; Hu Zhou; Alice Sze-Tsai Wong; Xiao-Kun Zhang; Jin-Zhang Zeng
Journal:  FASEB J       Date:  2010-09-16       Impact factor: 5.191

2.  VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Authors:  I Soo; K L Madsen; Q Tejpar; B C Sydora; R Sherbaniuk; B Cinque; L Di Marzio; M Grazia Cifone; C Desimone; R N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

3.  The role of bile acids in cellular invasiveness of gastric cancer.

Authors:  Yu-Chung Wu; Chang-Fang Chiu; Chung-Tzu Hsueh; Chung-Tsen Hsueh
Journal:  Cancer Cell Int       Date:  2018-05-21       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.